Higher compliance with ERAS pathways improves postoperative outcomes

Enhanced recovery pathways significantly reduced postoperative morbidity and LOS in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Among 150 patients studied, average compliance reached 77.6%, showing a notable negative correlation with postoperative complications and delays in return to intended oncological therapy. Specifically, patients with compliance below 71.6% faced increased morbidity. These findings support the efficacy of ERAS implementations but highlight the need for multicenter studies to bolster these results.